Literature DB >> 18075288

The impact of thyroidectomy on psychiatric symptoms and quality of life.

P Miccoli1, M N Minuto, R Paggini, P Rucci, A Oppo, G Donatini, F Golia, L Novelli, M Carlini, L Dell'Osso.   

Abstract

INTRODUCTION: Existing trials investigated the impact of medical treatment of thyroid disorders on health-related quality of life (QOL) and psychiatric symptoms. The aim of this prospective study is to analyze the impact of thyroid surgery on QOL and severity of psychiatric symptoms.
MATERIALS AND METHODS: Forty-seven patients undergoing thyroid surgery (TS) were assessed before thyroidectomy (T0) and 37 also after surgery, >or=6 months after euthyroidism was achieved (T1). QOL and psychiatric symptoms were evaluated at T0 and T1 using the Medical Outcomes Study Short Form Survey (SF-36) and the Symptom Checklist-90 (SCL-90-R). Scores at T0 were compared with those of patients undergoing surgery for non-thyroidal disease and the SF-36 scores were also compared with the normative Italian sample. Changes in QOL and psychiatric symptoms between T0 and T1 were also examined.
RESULTS: Health-related QOL in TS patients before surgery was poorer than in the comparison group on the SF-36 mental component summary measure and social functioning. Mental health improved significantly after surgery but social functioning remained markedly impaired. A significant reduction in the severity of psychiatric symptoms was observed. DISCUSSION: Our results indicate that even long after euthyroidism is achieved after surgery, patients show a significant improvement of mental health and a reduction of psychiatric symptoms. Nevertheless, patients continue to have a poorer QOL compared to the Italian normative sample.

Entities:  

Mesh:

Year:  2007        PMID: 18075288     DOI: 10.1007/BF03349227

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  25 in total

1.  Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients.

Authors:  B Biondi; E A Palmieri; S Fazio; C Cosco; M Nocera; L Saccà; S Filetti; G Lombardi; F Perticone
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

Review 2.  Gene regulation by thyroid hormone.

Authors:  Y Wu; R J Koenig
Journal:  Trends Endocrinol Metab       Date:  2000-08       Impact factor: 12.015

3.  Dimensions of outpatient neurotic pathology: comparison of a clinical vrsus an empirical assessment.

Authors:  L R Derogatis; L Covi; R S Lipman; K Rickels
Journal:  J Consult Clin Psychol       Date:  1970-04

4.  An analysis of the sources and quantity of 3,5,3'-triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum.

Authors:  F R Crantz; J E Silva; P R Larsen
Journal:  Endocrinology       Date:  1982-02       Impact factor: 4.736

5.  Observational study on the stability of the psychological status during normal pregnancy and increased blood levels of neuroactive steroids with GABA-A receptor agonist activity.

Authors:  Anna Maria Paoletti; Sandra Romagnino; Rossana Contu; Marisa Margherita Orrù; Maria Francesca Marotto; Pierina Zedda; Stefano Lello; Giovanni Biggio; Alessandra Concas; Gian Benedetto Melis
Journal:  Psychoneuroendocrinology       Date:  2006-01-06       Impact factor: 4.905

6.  Naltrexone and buprenorphine combination in the treatment of opioid dependence.

Authors:  G Gerra; A Fantoma; A Zaimovic
Journal:  J Psychopharmacol       Date:  2006-01-09       Impact factor: 4.153

7.  Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction.

Authors:  Seref Gulseren; Leyla Gulseren; Zeliha Hekimsoy; Pinar Cetinay; Cigdem Ozen; Basak Tokatlioglu
Journal:  Arch Med Res       Date:  2006-01       Impact factor: 2.235

8.  Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine.

Authors:  B Biondi; S Fazio; C Carella; D Sabatini; G Amato; A Cittadini; A Bellastella; G Lombardi; L Saccà
Journal:  J Clin Endocrinol Metab       Date:  1994-05       Impact factor: 5.958

Review 9.  Quality of life in patients with benign thyroid disorders. A review.

Authors:  Torquil Watt; Mogens Groenvold; Ase Krogh Rasmussen; Steen Joop Bonnema; Laszlo Hegedüs; Jakob Bue Bjorner; Ulla Feldt-Rasmussen
Journal:  Eur J Endocrinol       Date:  2006-04       Impact factor: 6.664

10.  Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxine treatment.

Authors:  F Monzani; P Del Guerra; N Caraccio; C A Pruneti; E Pucci; M Luisi; L Baschieri
Journal:  Clin Investig       Date:  1993-05
View more
  8 in total

Review 1.  Morbidity following thyroid surgery: acceptable rates and how to manage complicated patients.

Authors:  M N Minuto; S Reina; E Monti; G L Ansaldo; E Varaldo
Journal:  J Endocrinol Invest       Date:  2019-05-23       Impact factor: 4.256

2.  Quality of life (QoL) in patients with benign thyroid goiters (pre- and post-thyroidectomy): a prospective study.

Authors:  Anjali Mishra; Mayilvaganan Sabaretnam; Gyan Chand; Gaurav Agarwal; Amit Agarwal; Ashok Kumar Verma; Saroj Kanta Mishra
Journal:  World J Surg       Date:  2013-10       Impact factor: 3.352

3.  Five-year longitudinal evaluation of quality of life in a cohort of patients with differentiated thyroid carcinoma.

Authors:  Massimo Giusti; Giulia Melle; Monica Fenocchio; Lorenzo Mortara; Francesca Cecoli; Valeria Caorsi; Diego Ferone; Francesco Minuto; Elda Rasore
Journal:  J Zhejiang Univ Sci B       Date:  2011-03       Impact factor: 3.066

4.  Changes in quality of life after thyroidectomy in subjects with thyroid cancer in relation to the dose of levothyroxine.

Authors:  M L Monzani; F Piccinini; G Boselli; R Corleto; G Margiotta; R P Peeters; M Simoni; G Brigante
Journal:  J Endocrinol Invest       Date:  2022-08-21       Impact factor: 5.467

5.  Improvement of quality of life in patients with benign goiter after surgical treatment.

Authors:  Branka R Bukvic; Vladan R Zivaljevic; Sandra B Sipetic; Aleksandar D Diklic; Katarina M Tausanovic; Ivan R Paunovic
Journal:  Langenbecks Arch Surg       Date:  2014-07-08       Impact factor: 3.445

6.  Relationship between age and outcome in thyroid surgery: a prospective observational study.

Authors:  Navid Tabriz; Verena Nicole Uslar; Inga Tabriz; Dirk Weyhe
Journal:  Innov Surg Sci       Date:  2017-06-29

7.  Quality of life is not affected by thyroid surgery in nontoxic benign goitre in long-term surveillance-A prospective observational study.

Authors:  Navid Tabriz; Verena N Uslar; Inga Tabriz; Dirk Weyhe
Journal:  Endocrinol Diabetes Metab       Date:  2020-02-26

8.  Nontoxic Goiter (NTG) and Radioiodine: What Do Patients Think About It? Quality of Life in Patients with NTG Before and After 131-I Therapy.

Authors:  Sonia Kaniuka-Jakubowska; Anna Lewczuk; Mikołaj Majkowicz; Maciej Piskunowicz; Krystyna Mizan-Gross; Adam Zapaśnik; Mariusz Kaszubowski; Piotr Lass; Krzysztof Sworczak
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-16       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.